Results 241 to 250 of about 196,988 (294)

An update on the landscape of collagen bioactive fragments

The FEBS Journal, EarlyView.
The remodeling of the extracellular matrix releases collagen bioactive fragments, which exert molecular functions and regulate numerous biological processes via several signaling pathways. Here, we summarize the latest findings describing the roles of major bioactive fragments from collagens I, IV, VI, and XVIII in various physiological and ...
Sylvie Ricard‐Blum, Julie Fradette
wiley   +1 more source

Sickle cell related cardiomyopathy and cardiovascular autonomic dysfunction. [PDF]

Front Cardiovasc Med
Hartnett J, Connolly N, Quinn S, Murphy R, Tuohy E, Curtain J, Mogensen J, Kenny RA, Maree AO.   +8 more
europepmc   +1 more source

Long‐Term Follow‐Up of Radiofrequency Slow Pathway Ablation for Atrioventricular Nodal Re‐Entrant Tachycardia: Late Outcomes

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Slow pathway radiofrequency ablation is an effective treatment for atrioventricular nodal re‐entrant tachycardia (AVNRT) but has been reported in some series to result in late atrioventricular block. We examined our local experience with a retrospective review. Methods A retrospective review of all patients undergoing slow pathway
Emma Yaakop, Stephen Browitt, Catherine Cruickshank, Judy Greenslade, Iain Melton, Matthew Daly, Geoffrey Clare, Ross Downey, Daniel Garofalo, Ian Crozier   +9 more
wiley   +1 more source

Beyond Hypertrophy: A Case of Mid-ventricular Obstructive Hypertrophic Cardiomyopathy With Apical Sequestration. [PDF]

Cureus
Taoussi O, Scadi S, Mokhtari M, Benouna G, Merzouk F.   +4 more
europepmc   +1 more source

Early Initiation of Enzyme Replacement Therapy in Infantile Onset Pompe Disease Improves Cardiac Outcomes: A Longitudinal Analysis. [PDF]

JIMD Rep
Cohen JL, Beaman MM, Rodriguez-Rassi E, Stafford VG, Smith PB, Landstrom AP, Kishnani PS.   +6 more
europepmc   +1 more source

An Atypical Presentation of Pulmonary Oedema Secondary to Suspected Anabolic Steroid-Induced Cardiomyopathy. [PDF]

Cureus
Davies A.
europepmc   +1 more source

Prevalence and risk factors of pulmonary hypertension in maintenance hemodialysis patients based on echocardiography. [PDF]

Medicine (Baltimore)
Zhou J.
europepmc   +1 more source

MELAS Syndrome Presenting with Hypertrophic Cardiomyopathy and Advanced Heart Failure: A Multisystem Diagnostic Challenge. [PDF]

J Clin Med
Dodulík J, Lazárová M, Kapsová E, Václavík J.   +3 more
europepmc   +1 more source

Study on the ultrasonic myocardial mechanics of left atrioventricular coupling in IBSH patients. [PDF]

Front Cardiovasc Med
Jia H, Ma T, Hu X, Nan J, Qi S, Mu Y, Guan L.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Left ventricular hypertrophy

Current Treatment Options in Cardiovascular Medicine, 1999
The presence of left ventricular hypertrophy (LVH) as a treatable entity is of particular importance in patients with primary hypertension. Because LVH is associated with a strong risk of adverse clinical events (eg, heart failure, ischemic events, and cardiovascular death) and because evidence from retrospective studies suggests that regression of LVH,
Ernst E. Van der Wall, Arnoud Van der Laarse, Babette M. Pluim, Albert V. G. Bruschke   +3 more
openaire   +3 more sources